Declared chapter 11 bankruptcy in Mar 2023
TCDA - Tricida, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
TCDA price evolution
TCDA
| (in millions $) | 29 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $82.48 | $102.38 | $128 | $145.54 |
| Long term investments | ||||
| Property, plant & equipment | $11.39 | $11.91 | $12.42 | $12.93 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $93.88 | $114.29 | $140.41 | $168.51 |
| Current liabilities | ||||
| Accounts payable | $4.39 | $3.74 | $5.54 | $10.02 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $16.93 | $20.05 | $24.99 | $29.48 |
| Long term debt | $195.35 | $195.12 | $194.89 | $127.51 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $229.98 | $225.51 | $230.71 | $168.29 |
| Shareholders' equity | ||||
| Retained earnings | -$881.96 | -$856.2 | -$827.66 | -$810.36 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | 31 Jan 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $145.54 | $314 | $312.7 | $244.3 |
| Long term investments | ||||
| Property, plant & equipment | $12.93 | $14.9 | $12.1 | $1.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $168.51 | $351.7 | $371.8 | $247.8 |
| Current liabilities | ||||
| Accounts payable | $10.02 | $3.5 | $5.9 | $8.5 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $29.48 | $34.3 | $39.8 | $14.8 |
| Long term debt | $127.51 | $195.3 | $58.4 | $38.1 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $168.29 | $242.8 | $107.9 | $53.3 |
| Shareholders' equity | ||||
| Retained earnings | -$810.36 | -$633.8 | -$369 | -$192.2 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||